We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,089 hedge funds and large institutions have $105B invested in Allergan plc in 2015 Q1 according to their latest regulatory filings, with 298 funds opening new positions, 549 increasing their positions, 185 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

645% more first-time investments, than exits

New positions opened: 298 | Existing positions closed: 40

197% more repeat investments, than reductions

Existing positions increased: 549 | Existing positions reduced: 185

63% more capital invested

Capital invested by funds: $64.6B → $105B (+$40.6B)

48% more funds holding in top 10

Funds holding in top 10: 123182 (+59)

30% more funds holding

Funds holding: 8401,089 (+249)

15% more call options, than puts

Call options by funds: $2.92B | Put options by funds: $2.55B

Holders
1,089
Holders Change
+249
Holders Change %
+29.64%
% of All Funds
29.01%
Holding in Top 10
182
Holding in Top 10 Change
+59
Holding in Top 10 Change %
+47.97%
% of All Funds
4.85%
New
298
Increased
549
Reduced
185
Closed
40
Calls
$2.92B
Puts
$2.55B
Net Calls
+$370M
Net Calls Change
-$860M
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
26
Fred Alger Management
New York
$894M +$120M +421,625 +16%
Norges Bank
27
Norges Bank
Norway
$875M +$334M +1,173,244 +66%
JP Morgan Chase
28
JP Morgan Chase
New York
$849M +$324M +1,136,362 +66%
JSP
29
Jackson Square Partners
California
$835M +$800M +2,805,318 New
Massachusetts Financial Services
30
Massachusetts Financial Services
Massachusetts
$803M +$83.3M +292,019 +12%
SCM
31
Steadfast Capital Management
New York
$706M +$459M +1,608,911 +211%
GE
32
General Electric
Ohio
$649M +$672K +2,357 +0.1%
State Farm Mutual Automobile Insurance
33
State Farm Mutual Automobile Insurance
Illinois
$640M +$613M +2,149,118 New
UBS AM
34
UBS AM
Illinois
$633M +$321M +1,124,166 +112%
Goldman Sachs
35
Goldman Sachs
New York
$621M +$100M +351,618 +20%
BA
36
BlackRock Advisors
Delaware
$619M +$130M +456,019 +28%
GCM
37
Glenview Capital Management
New York
$590M +$40.2M +140,840 +8%
Parnassus Investments
38
Parnassus Investments
California
$581M +$315M +1,105,893 +131%
APG Asset Management
39
APG Asset Management
Netherlands
$579M +$25M +87,855 +5%
Wells Fargo
40
Wells Fargo
California
$568M +$184M +644,335 +51%
Bank of America
41
Bank of America
North Carolina
$546M -$6.44M -22,587 -1%
LPC
42
Lone Pine Capital
Connecticut
$545M +$522M +1,832,314 New
Deutsche Bank
43
Deutsche Bank
Germany
$516M +$114M +401,560 +30%
SIG
44
Senator Investment Group
New York
$506M -$92.7M -325,200 -16%
PI
45
Putnam Investments
Massachusetts
$493M -$14.3M -50,047 -3%
UBS Group
46
UBS Group
Switzerland
$485M +$180M +631,134 +63%
JP
47
Jana Partners
New York
$483M +$462M +1,621,852 New
MCM
48
Marsico Capital Management
Colorado
$482M +$99.8M +350,158 +28%
IC
49
Institutional Capital
Illinois
$471M +$390M +1,367,167 +638%
O
50
OrbiMed
New York
$470M +$25.7M +89,987 +6%

AGN Hedge Fund Activity: Q1 2015 in Review

1,089 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2015, worth a combined $105B — up 63% from $64.6B a quarter earlier.

Buyers outnumbered sellers: 298 funds opened new AGN positions and 40 closed out — a net gain of 258 holders — while 549 added to existing stakes and 185 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $2.6B. The largest seller was Renaissance Technologies, exiting entirely with an estimated $117M sold.

  • 1,089 institutional investors held Allergan plc (AGN) as of Q1 2015, up from 840 in Q4 2014.
  • Funds reported $105B of Allergan plc stock for Q1 2015, up 63% quarter-over-quarter.
  • 298 funds opened new Allergan plc positions in Q1 2015 and 40 closed out, a net change of +258 holders.
  • The largest Allergan plc buyer in Q1 2015 was T. Rowe Price Associates, an estimated $2.6B added.
  • The largest Allergan plc seller in Q1 2015 was Renaissance Technologies, an estimated $117M sold.

Based on aggregated 13F filings for Q1 2015.